Physician profile
Anand Gopal
NPI 1720571722
$2,583.85
in general payments reported to CMS, 2019-2025
18 companies · $335 in 2025
The $335 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $182 · 2022: $929 · 2023: $651 · 2024: $487 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,473.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $491.67 | 2022-2023 | Clareon |
| Bausch & Lomb Americas INC. | $412.54 | 2023-2024 | Stellaris, Stellaris |
| Apellis Pharmaceuticals, INC. | $283.50 | 2022-2025 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $204.73 | 2024-2025 | Eylea Hd |
| Genentech, INC. | $194.07 | 2022-2024 | Vabysmo |
| Sight Sciences, INC. | $127.55 | 2023 | Omni Surgical System |
| Genentech USA, INC. | $121.87 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $118.29 | 2022 | |
| Biogen, INC. | $95.60 | 2023 | |
| Alimera Sciences, INC. | $81.36 | 2023-2024 | Iluvien, Yutiq |
| Glaukos Corporation | $76.83 | 2022 | |
| Dutch Ophthalmic, USA | $69.88 | 2023 | Tissueblue, Eva, Combined Machine |
| Oyster Point Pharma, INC. | $32.74 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $20.24 | 2025 | Lumera 700 |
| Abbvie INC. | $19.52 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.77 | 2025 | Izervay |
| Stryker Corporation | $16.35 | 2022 | |
| Eyepoint US, INC. | $16.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anand Gopal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.